Skip to main content
Premium Trial:

Request an Annual Quote

Exelixis Lays Off 62 Employees

NEW YORK, June 30 (GenomeWeb News) - Exelixis announced today that it has eliminated 62 jobs, or approximately 11 percent of the company's workforce.


According to an official company statement, most of the layoffs will be from Exelixis' research and discovery organizations as the company attempts to consolidate it resources to generate new investigational new drug applications and advance them through clinical development.


The company said it expects the restructuring to result in at least $5 million in savings in 2004, excluding the estimated $2 million loss due to severance benefits and other restructuring costs anticipated in Q2 of this year.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.